November 14 - 18, 2023
Salt Lake City, Utah
Visit Asuragen, a Bio-Techne brand at Booth #1311 and join us at these sessions to learn how our products & services can empower you to provide better answers.
For highly sensitive detection of leukemic fusions using widely available qPCR equipment, Asuragen’s QuantideX qPCR BCR-ABL* kits offer IVD or RUO testing capabilities for molecular laboratories of any size. Learn about key features of these assays and see real-world performance data.
Holli M. Drendel, PhD, FACMGG
Director, Molecular Pathology
Laboratory Carolinas Pathology Group
*For Research use only.
Asuragen’s simple and scalable AmplideX technology, the gold standard for FMR1 analysis, has been expanded to cover other repeat disorder genes, copy number assays, and highly multiplexed variant detection. This workshop will report the experience of a clinical lab that adopted the AmplideX SMN1/2 Plus Kit* for detection of SMN1 and SMN2 copy numbers and genetic variants.
Sarah S. Murray, PhD, FACMG
Clinical Professor, Department of Pathology
Director, Medical Genetics and Genomics University of California San Diego
*For Research use only.
Asuragen is excited to provide free headshot opportunities to all AMP attendees.
Visit these posters to learn about molecular diagnostic advances.
G016
Brian Haynes, PhD, CSO, Asuragen & Head of Bioinformatics, Molecular Diagnostics Division
Friday, November 17th, 9:15am -10:15am
G030
Brennan Greenlee, MS, Sr. Research Associate, Asuragen
Friday, November 17th, 9:15am -10:15am.
ST078
Julie Thibert, MS, Scientist, Asuragen
Friday, November 17th, 9:15am -10:15am.
H063
Ila Wolf, PhD, Scientist, Asuragen
Saturday, November 18th, 9:15am -10:15am
* For Research Use Only. Not for use in Diagnostic procedures.
231 S Edison St, Salt Lake City, UT 84111
Distance from Conv Center: 4 minute drive or 12 minute walk
Wednesday, November 15 at 6:00 PM